Impact of a Tripartite Collaboration between Oncologist, Pharmacist and Diabetologist in the Management of Patients with Diabetes Starting Chemotherapy: The ONCODIAB Trial

Impact of a Tripartite Collaboration between Oncologist, Pharmacist and Diabetologist in the Management of Patients with Diabetes Starting Chemotherapy: The ONCODIAB Trial

Background: Diabetes negatively impacts cancer prognosis. The objective of this work was to evaluate a tripartite oncologist–pharmacist–diabetologist collaboration in the management of patients with diabetes starting chemotherapy. Patients and Methods: The prospective ONCODIAB study (NCT04315857) in...

Full description

Bibliographic Details
Main Authors: Justine Paris, Pauline Legris, Madeline Devaux, Stephanie Bost, Pauline Gueneau, Cedric Rossi, Sylvain Manfredi, Benjamin Bouillet, Jean-Michel Petit, Pauline Pistre, Mathieu Boulin
Format: Article
Language:English
Published: MDPI AG 2023-09-01
Series:Cancers
Subjects:
cancer
diabetes
diabetologist
pharmacist
medication optimization
Online Access:https://www.mdpi.com/2072-6694/15/18/4544

Internet

https://www.mdpi.com/2072-6694/15/18/4544

Similar Items